Literature DB >> 32769655

Care for Incarcerated Pregnant People With Opioid Use Disorder: Equity and Justice Implications.

Chris Ahlbach1, Carolyn Sufrin, Rebecca Shlafer.   

Abstract

With the simultaneous rise in maternal opioid use disorder (OUD) and the incarceration of pregnant people in the United States, we must ensure that prisons and jails adequately address the health and well-being of incarcerated pregnant people with OUD. Despite long-established, clear, and evidence-based recommendations regarding the treatment of OUD during pregnancy, incarcerated pregnant people with OUD do not consistently receive medication treatment and are instead forced into opioid withdrawal. This inadequate care raises multiple concerns, including issues of justice and equity, considerations regarding the legal and ethical obligations of the provision of health care, and violations of the medical and legal rights of incarcerated people. We offer recommendations for improving care for this often-ignored group.

Entities:  

Mesh:

Year:  2020        PMID: 32769655      PMCID: PMC7483637          DOI: 10.1097/AOG.0000000000004002

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  29 in total

1.  ACOG Committee Opinion No. 511: Health care for pregnant and postpartum incarcerated women and adolescent females.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-11       Impact factor: 7.661

2.  Health care of pregnant women in U.S. state prisons.

Authors:  Ginette G Ferszt; Jennifer G Clarke
Journal:  J Health Care Poor Underserved       Date:  2012-05

3.  Release from prison--a high risk of death for former inmates.

Authors:  Ingrid A Binswanger; Marc F Stern; Richard A Deyo; Patrick J Heagerty; Allen Cheadle; Joann G Elmore; Thomas D Koepsell
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

4.  Withdrawal from methadone in US prisons: cruel and unusual?

Authors:  M-J Milloy; Evan Wood
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

5.  Buprenorphine Treatment Divide by Race/Ethnicity and Payment.

Authors:  Pooja A Lagisetty; Ryan Ross; Amy Bohnert; Michael Clay; Donovan T Maust
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

6.  Medication-Assisted Opioid Treatment Prescribers in Federally Qualified Health Centers: Capacity Lags in Rural Areas.

Authors:  Emily B Jones
Journal:  J Rural Health       Date:  2017-08-26       Impact factor: 4.333

7.  White opioids: Pharmaceutical race and the war on drugs that wasn't.

Authors:  Julie Netherland; Helena Hansen
Journal:  Biosocieties       Date:  2017-06-28

8.  AGOG Committee Opinion No. 473: substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-01       Impact factor: 7.661

9.  Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Authors:  Josiah D Rich; Michelle McKenzie; Sarah Larney; John B Wong; Liem Tran; Jennifer Clarke; Amanda Noska; Manasa Reddy; Nickolas Zaller
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

10.  Opiate withdrawal complicated by tetany and cardiac arrest.

Authors:  Irfanali R Kugasia; Nehad Shabarek
Journal:  Case Rep Crit Care       Date:  2014-06-15
View more
  1 in total

1.  The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series.

Authors:  Caroline Shadowen; Frederick Gerard Moeller; Caitlin E Martin
Journal:  J Addict Med       Date:  2021 Jul-Aug 01       Impact factor: 3.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.